Type 1 Diabetes
Off-label semaglutide, tirzepatide lower HbA1c and body weight in type 1 diabetes
Adults with type 1 diabetes using either semaglutide or tirzepatide off-label had greater decreases in body weight and HbA1c than those not treated with either medication, according to a speaker.
Top in endocrinology: Type 1 diabetes progression in children; tubeless insulin patch pump
Higher consumption of rye, oats and fruits increased the risk for progression to type 1 diabetes among children at high genetic risk for the disease, study results showed.
FDA clears implantable CGM with sensor that lasts up to 1 year
The FDA has cleared a continuous glucose monitoring system with an implantable sensor that can be worn for up to 1 year for adults aged 18 years and older with type 1 or type 2 diabetes, according to a press release.
Eating more oats, fruits in early childhood may raise risk for type 1 diabetes
Young children at high genetic risk for type 1 diabetes may be more likely to progress to the disease based on their dietary intake, according to a presenter at the European Association for the Study of Diabetes annual meeting.
QWINT: Once-weekly insulin tied to similar HbA1c reduction as insulin degludec
Once-weekly insulin efsitora alfa provided similar reductions in HbA1c as once-daily insulin degludec among insulin-naive adults with type 2 diabetes and adults with type 1 diabetes previously receiving a basal and bolus insulin analog.
Q&A: Use person-centered approach when discussing type 1 diabetes screening
With new guidance now available on monitoring people with early-stage type 1 diabetes, it is crucial for providers to encourage people at high risk to get tested, according to a presenter.
Most diabetes care and education specialists follow guidance on type 1 diabetes screening
Most diabetes care and education specialists said they believe it is important to screen for presymptomatic type 1 diabetes, though some said they had limited knowledge regarding teplizumab-mzwv, according to a presenter.